Fuertes, Thelma C.
HRN: 22-58-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/07/2025
05/13/2025
IV
2.25g
Q6H
Infected Wound Left Foot
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes